This test is most useful if any of these apply to you.
Your complete blood count reports a handful of small numbers about your red blood cells, and MCH (mean corpuscular hemoglobin) is one most people skip past. It is calculated from your hemoglobin and red-cell count, then reported as the average amount of hemoglobin inside one red cell. When it falls, the question is usually whether new cells are being made with too little hemoglobin because of iron shortage, thalassemia trait, or another cause.
A single MCH value can point toward iron deficiency, an inherited blood trait you never knew you carried, or a distorted diabetes reading. It is one of the steadier numbers in your blood, so a single measurement means something. And you already get it every time you run a blood count.
MCH is the average amount of hemoglobin packed inside one red blood cell. Labs report it as a very small weight per cell. It answers a narrow question: on average, how much oxygen-carrying protein did your body manage to load into each cell?
Three numbers on the count sound almost identical and get mixed up constantly. MCV (mean corpuscular volume) is the size of the cell. MCH is how much hemoglobin is inside it. MCHC (mean corpuscular hemoglobin concentration) is how concentrated that hemoglobin is. MCHC is the better clue to whether cells are truly pale. Low MCH usually travels with low MCV, because small cells hold less hemoglobin.
When MCH is low, each red cell carries less hemoglobin than expected. The common cause is iron deficiency: without enough iron, your marrow cannot build hemoglobin well, so each new cell comes out light. The other important cause is thalassemia, an inherited difference in how you make hemoglobin.
MCH can add information before hemoglobin has fallen, but it is not a substitute for ferritin. In healthy young adults whose red-cell values were still in the usual range, lower MCH and MCV tracked with lower ferritin and weaker memory and executive-task performance. A separate UK Biobank genetic analysis found MCH was linked to some cognitive test scores in a way that supported, but did not prove for any one person, a causal direction from red-cell hemoglobin traits to cognition. This is early evidence, not settled fact, but it is a reason not to dismiss a low-normal MCH.
One useful thing MCH does has nothing to do with feeling sick. It can flag people who carry a thalassemia trait but look completely healthy on every other measure. In 486 Thai men with normal hemoglobin, a low-MCH screen caught every alpha-zero thalassemia carrier and correctly cleared about 89 of 100 non-carriers. That is strong screening performance in a high-prevalence setting, not a standalone diagnosis.
MCH also tracks how many alpha-globin genes are missing: the more genes were missing, the lower the MCH. A similar red-cell model works in non-anemic pregnant women. This matters because two carriers can pass a serious blood disorder to a child, and it is knowable long before a pregnancy, from a number you may already have.
A high MCH usually means your red cells are unusually large, and large cells carry more hemoglobin. The classic cause is a shortage of vitamin B12 or folate, the two nutrients your marrow needs to divide cells properly. Alcohol, thyroid problems, liver disease, and some medicines can push it up too. So a high value is a prompt to look for why the cells are large, not a signal that more hemoglobin is better.
Here the picture turns, because in some settings a high MCH is the worrying one. Among people with a recent heart attack or unstable chest pain who were not anemic, those with higher MCH went on to have more heart attacks, strokes, and cardiac deaths over follow-up. Across the general US population, MCH followed a U-shaped curve with death from any cause, with higher risk at both low and high values and the lowest observed risk in the middle of the measured range.
| Who Was Studied | What Was Compared | What They Found |
|---|---|---|
| 318 non-anemic people with a recent heart attack or unstable chest pain (from a study of 393 acute coronary syndrome patients) | Higher versus lower MCH at admission | Higher MCH went with more later heart attacks, strokes, and cardiac deaths |
| 21,203 US adults | MCH across its full range | Risk of death from any cause was higher at both low and high MCH, and lowest in the middle |
| 486 Thai men with normal hemoglobin | MCH against genetic testing for alpha-zero thalassemia | Caught every carrier and correctly cleared about 89 of 100 non-carriers |
Sources: Zhang et al. 2022 (acute coronary syndrome); Li et al. 2023 (US mortality cohort); Phanthong et al. 2025 (thalassemia screening).
This is where MCH trips people up. Low can be bad and high can be bad, so it is not a number you push in one direction. Read it less as a score to optimize and more as a direction finder: a low value points at iron or thalassemia, a high value at nutrient shortage or larger cells, and both extremes tend to travel with worse health for different reasons.
Related work on MCHC, the concentration index rather than the content index, points the same way. Low MCHC tracked with roughly a quarter higher risk of death from any cause in people with high blood pressure, and with worse outcomes in heart failure, especially alongside reduced kidney function. Those are a different measurement than MCH, so treat them as supporting context rather than direct evidence about this number.
If you track your blood sugar with HbA1c, a test that estimates your average sugar over about three months, MCH quietly matters. HbA1c is built on hemoglobin, so red-cell traits can skew the category it puts you in. In 21,844 people, low or high MCH or MCV was associated with a higher risk of an erroneous HbA1c-based category for at least 25% of patients. Low MCH tended to push HbA1c higher relative to fasting glucose, while high MCH tended to push it lower. If your iron markers are off and HbA1c looks surprising, compare it with fasting glucose or another glucose measure rather than treating HbA1c as the only answer.
MCH is steady within a person. In one short- and medium-term study, its natural within-person variation was under half a percent, among the lowest of the red-cell measures in that study, though MCV and MCHC come out similarly stable in other datasets. That has two consequences. A single MCH is useful, and because it barely drifts on its own, a clear shift on repeat CBCs deserves a second look.
Because new red cells take weeks to replace old ones, do not expect MCH to jump quickly after you start iron. The reticulocyte hemoglobin test reads the hemoglobin in your youngest cells, so it moves faster if you want an early read on whether iron treatment is working.
An abnormal MCH is a starting point, not a diagnosis. If yours is low, order iron studies: ferritin, which reflects your iron stores, and transferrin saturation, which shows how much iron is in transit. Low MCH with low ferritin usually confirms iron deficiency, and the real task is finding and treating the cause of the loss, not just swallowing iron.
If your iron is normal but MCH stays low, hemoglobin electrophoresis can check for beta-thalassemia and common hemoglobin variants. Alpha-thalassemia often needs targeted alpha-globin DNA testing, especially if your family comes from the Mediterranean, the Middle East, South or Southeast Asia, or Africa, where these traits are more common.
RDW, the red cell distribution width, helps sort the pattern, because iron deficiency tends to widen the spread of cell sizes while a thalassemia trait usually keeps them more uniform. The Mentzer Index (MCV divided by red-cell count) is another quick way to lean toward beta-thalassemia trait versus iron deficiency in microcytic anemia. If your MCH is high, check vitamin B12 and folate, and consider alcohol, thyroid, liver, and medication causes. Do not lean on any one index alone; classifying anemia by cell size misfires in most primary care cases because so many anemias look normal-sized. When the pattern is unclear or an electrophoresis comes back abnormal, a hematologist is the right call.
Evidence-backed interventions that affect your MCH level
MCH is best interpreted alongside these tests.
MCH is included in these pre-built panels.